Wire Stories
Noxopharm Reports Veyonda�s Potential in Late-Stage Cancer at ASCO 2020
SYDNEY–(BUSINESS WIRE)–#clinicaltrials–At the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting, Noxopharm, a clinical-stage Australian oncology drug development company, has...